Search Results for: Anil Potti

Lead author of major breast cancer study announced at ASCO co-authored two corrected papers with Anil Potti

One of the biggest stories so far out of the American Society of Clinical Oncology (ASCO) meeting that just ended in Chicago was that of T-DM1, which, according to Ivan’s Reuters colleagues, “extended the length of time breast cancer patients lived without their disease getting worse.” (The news was even the subject of an embargo … Continue reading Lead author of major breast cancer study announced at ASCO co-authored two corrected papers with Anil Potti

A “retraction in part” for Anil Potti and colleagues, in Molecular Cancer Therapeutics

A partial retraction has joined the ten retractions and five corrections of Anil Potti’s papers, this one of a 2008 paper in Molecular Cancer Therapeutics. The move comes 14 months after the retraction of the Nature Medicine paper upon which much of the Molecular Cancer Therapeutics paper was based. Here’s the notice:

Missouri medical board reprimands Anil Potti

Anil Potti, the former Duke oncology researcher who has now retracted ten papers amid continuing investigations into his work, has been reprimanded by the Missouri medical board. The reprimand, which was first reported by DukeCheck, became effective on March 6. In it, the Missouri State Board of Registration for the Healing Arts noted that the … Continue reading Missouri medical board reprimands Anil Potti

Updated: Anil Potti out at Coastal Cancer Center; practice blames Duke for glowing recommendations

Anil Potti, the former Duke oncologist who has now retracted ten papers, is no longer listed as a staff member at the oncology practice that hired him sometime last year. The development, first reported by Duke Check, follows a 60 Minutes segment last week focused on Potti and Duke. Duke Check also noted that a … Continue reading Updated: Anil Potti out at Coastal Cancer Center; practice blames Duke for glowing recommendations

The Anil Potti retraction record so far

A 60 Minutes segment Sunday on Anil Potti has drawn national attention to the case, so we thought this would be a good time to compile all of the retractions and corrections in one place. Duke has said that about a third of Potti’s 40-some-odd papers would be retracted, and another third would have “a … Continue reading The Anil Potti retraction record so far

Two mega-corrections for Anil Potti in the Journal of Clinical Oncology

Anil Potti can add two corrections to his less-and-less impressive publication record. The mega-corrections — part of what we are close to being ready to call a trend in errata notices — in the Journal of Clinical Oncology (JCO) are, however, quite impressive, each with at least a dozen points. One of the corrections, for … Continue reading Two mega-corrections for Anil Potti in the Journal of Clinical Oncology

Anil Potti and colleagues retract ninth paper, this one in JCO

Former Duke oncology researcher Anil Potti has retracted another paper, marking his ninth withdrawal. The notice in the Journal of Clinical Oncology (JCO) reads: “An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer” by Holly K. Dressman, Andrew Berchuck, Gina Chan, Jun Zhai, Andrea Bild, Robyn Sayer, Janiel Cragun, Jennifer Clarke, … Continue reading Anil Potti and colleagues retract ninth paper, this one in JCO

Seven retractions, a resignation, and lawsuit settlements haven’t stopped Anil Potti from publishing

“Neither snow nor rain nor heat nor gloom of night” keeps U.S. mail carriers from delivering your letters and packages, and neither seven retractions, nor being forced to resign, nor malpractice settlements (and an ongoing case) keeps former Duke oncologist Anil Potti from publishing papers. Potti’s latest effort, “A Pathway-Based Approach to Identify Molecular Biomarkers in … Continue reading Seven retractions, a resignation, and lawsuit settlements haven’t stopped Anil Potti from publishing

Anil Potti reprimanded by North Carolina state medical board, as lawsuit settlements surface

There are a few new developments in the case of Anil Potti, the former Duke oncologist who resigned amidst an investigation into clinical trials he was running — and has been forced to retract seven papers, at last count. Over the weekend, The Cancer Letter, which has been out front on this case, noted that … Continue reading Anil Potti reprimanded by North Carolina state medical board, as lawsuit settlements surface

Anil Potti failed to disclose corporate ties in yet-to-be-retracted JAMA papers

Anil Potti, the former cancer researcher whose work has become the subject of intense scrutiny that has already led to the retraction of five papers, didn’t tell the Journal of the American Medical Association (JAMA) about two very relevant corporate relationships he had when he published papers there, Retraction Watch has learned. JAMA has published two papers by … Continue reading Anil Potti failed to disclose corporate ties in yet-to-be-retracted JAMA papers